Standpoint Research
http://www.standpointresearch.comStandpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive six-year track record of more than 300 recommendations.
View Older Stories View More Recent Stories
-
Standpoint Research Downgraded Chevron (CVX) to Hold
-
Standpoint Research Downgrades Arch Coal (ACI) to Hold
-
Shares of Accenture (ACN) Seeing Action After Standpoint Downgrade; Barclays Defense
-
Standpoint Research Downgrades Accenture (ACN) to Hold; Fairly Valued
-
Standpoint Research Downgrades Accenture (ACN) to Hold
-
Standpoint Research Downgrades Cracker Barrel (CBRL) to Hold
-
Standpoint Research downgrades Turkcell (TKC) to Hold
-
Standpoint Research Downgrades Flour (FLR) to Hold
-
Standpoint Research Downgrades Adobe (ADBE) to Hold
-
Standpoint Research Downgrades Archer Daniels Midland (ADM) to Hold
-
Notable Analyst Rating Changes 09/13: KMX, NOK, HBAN, UAUA Upgraded; XOM, MA, HGSI, V Downgraded
-
Standpoint Research Starts Microsoft (MSFT) at Buy
-
Standpoint Research Initiates Coverage on The Buckle (BKE) with a Buy; Bad News Priced In, Rebound Not
-
Standpoint Research Starts The Buckle (BKE) at Buy
-
Standpoint Research Starts Intel (INTC) at Buy
-
Standpoint Research Downgrades Marsh & McLennan (MMC) to Hold
-
Standpoint Research Downgrades Qualcomm (QCOM) to Hold
-
Standpoint Research Downgrades Darden Restaurants (DRI) to Hold
-
Standpoint Research Upgrades FLIR Systems (FLIR) to Accumulate
-
Standpoint Research Starts Best Buy (BBY) at Buy
-
BofA (BAC) CEO Sends Vote of Confidence, Buys 30,000 Shares In the Open Market
-
Notable Analyst Rating Changes 8/23: FSLR, LOW, BAC Upgraded; BIDU, GPC, COCO Downgraded
-
Daily State of the Markets 8/23: The Big Question
-
Standpoint Research Upgrades Bank of America (BAC) to Accumulate
-
Standpoint Research Downgrades Checkpoint Software (CHKP) to Hold
-
Notable Analyst Rating Changes 08/19: ANF, DVN, NTES, MGA Upgraded; MOT, GLW, BRCD, CRUS Downgraded
-
Standpoint Research Starts The Gap (GPS) at Buy
-
Standpoint Research Starts Symantec (SYMC) at Buy
-
Standpoint Research Upgrades Abercrombie & Fitch Co. (ANF) to Accumulate
-
Standpoint Research Downgrades Motorola (MOT) to Hold
-
Standpoint Research Downgrades Mosaic (MOS) to Hold
-
Standpoint Research Downgrades AT&T (T) to Hold
-
Standpoint Research Downgrades Hansen Natural (HANS) to Hold; Valuation Call
-
Notable Analyst Rating Changes 08/05: SIRI, PCS, RGS, ACAS Upgraded; VMC, SD, CNW, Q Downgraded
-
Standpoint Research Upgrades MetroPCS (PCS) to Buy
-
Standpoint Research Upgrades McKesson (MCK) to Buy
-
Standpoint Research Downgrades AstraZeneca (AZN) to Hold
-
Standpoint Research Downgrades AstraZeneca plc (AZN) to Hold
-
Notable 52-Week High's and Low's of the Day 07/23: RVBD, ARMH, GENZ, INFA, NXTM High; GAP, BEC, WDC, YHOO Low
-
Standpoint Research Upgrades Western Digital (WDC) to Buy; Time to Get Back In
-
Standpoint Research Upgrades Western Digital (WDC) to Buy
-
Standpoint Research Downgrades Netease.com Inc. (NTES) to Hold
-
Standpoint Research Downgrades Syntel, Inc. (SYNT) to Hold
-
Standpoint Research downgrades Freeport-McMoRan Copper & Gold Inc. (FCX) to Hold
-
Standpoint Research Downgrades BP (BP) to Hold
-
Standpoint Research Initiates Coverage on Gilead Sciences (GILD) with a Buy
-
Standpoint Research Starts Gilead Sciences (GILD) at Buy
-
Standpoint Research Downgraded Cosan (CZZ) to Hold
-
Standpoint Research Upgrades Freeport-McMoRan (FCX) to Buy
-
Standpoint Research Downgrades PG, JNJ, VZ to Hold; Starts CVX at Buy

